Skip to main content

Nanoformulation Feasibility Study of Anticancer Drug

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Dec 14, 2015
Award amount: 
$75,000
Organization name: 
MAA Laboratories, Inc.
Principal Investigator: 
Jha, Anjani K
Grant program category: 
Business Financing
Grant program name: 
Company Inception Loan
Region: 
Research Triangle

MAA Laboratories, Inc. is a specialty pharmaceutical company that uses proprietary NanoContTM technology to combine nano-delivery systems and continuous manufacturing with a focus on oncology medicines. We reformulate existing anti-cancer drugs to improve one or more of the following aspects: therapeutic efficiency, targeted drug delivery, and/or mitigation of undesirable effects.

Fiscal year: 
2016